Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases. SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies. By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all. The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
View Top Employees from SeqOne GenomicsWebsite | https://seqone.com |
Revenue | $8.4 million |
Funding | $25.4 million |
Employees | 78 (60 on RocketReach) |
Founded | 2017 |
Address | 22, Rue Durand, Montpellier, Occitanie 34000, FR |
Phone | +33 9 54 40 42 84 |
Industry | Biotechnology Research, Healthcare Software, Big Data, Software Development & Design, Software, Data and Analytics, Biotechnology, Science and Engineering, Health Care |
SIC | SIC Code 873 Companies, SIC Code 73 Companies, SIC Code 737 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 51 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 513 Companies |
Looking for a particular SeqOne Genomics employee's phone or email?
The SeqOne Genomics annual revenue was $8.4 million in 2024.
60 people are employed at SeqOne Genomics.
SeqOne Genomics is based in Montpellier, Occitanie.
The NAICS codes for SeqOne Genomics are [54, 51, 5417, 541713, 54171, 541, 513].
The SIC codes for SeqOne Genomics are [873, 73, 737, 87].